Simvastatin Posttreatment Controls Inflammation and Improves Bacterial Clearance in Experimental Sepsis
Sepsis is characterized by a life-threatening organ dysfunction caused by an unbalanced host response to microbe infection that can lead to death. Besides being currently the leading cause of death in intensive care units worldwide, sepsis can also induce long-term consequences among survivors, such...
Saved in:
Main Authors: | Flora Magno de Jesus Oliveira, Cassiano Felippe Gonçalves-de-Albuquerque, Isabel Matos Medeiros de Moraes, Patrícia Alves Reis, Vinicius Novaes Rocha, Patrícia Torres Bozza, Adriana Ribeiro Silva, Hugo Caire de Castro Faria Neto |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2020/1839762 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reduced Plasma Nonesterified Fatty Acid Levels and the Advent of an Acute Lung Injury in Mice after Intravenous or Enteral Oleic Acid Administration
by: Cassiano Felippe Gonçalves de Albuquerque, et al.
Published: (2012-01-01) -
Effects of Posttreatments on the Storage Stability of Reclaimed Rubber
by: Na Lu, et al.
Published: (2021-01-01) -
Myopathy with Concurrent Tadalafil and Simvastatin
by: Maria Pia Gargante, et al.
Published: (2009-01-01) -
Severe Rhabdomyolysis Associated with Simvastatin and Role of
Ciprofloxacin and Amlodipine Coadministration
by: Nicolas De Schryver, et al.
Published: (2015-01-01) -
Radiologic Evaluation of Small Renal Masses (II): Posttreatment Management
by: J. Santos, et al.
Published: (2008-01-01)